The aim of the study was to investigate whether various beta-cell stimulatory drugs, given neonatally, influence the incidence of diabetes in BB rats. Newborn BB rats were treated twice daily for 6 days and diabetes development was observed during the following 200-day study period. Compared to a diabetes incidence of 63.8% in 163 control BB rats which received saline or were untreated, the percentage of experimental BB rats that developed diabetes was as follows in the different subgroups: arginineglucose: 47% (n 73, p < 0.02); glucagon: 37% (n 93, p < 0.0001); tolbutamide-glucose: 36% (n 58, p < 0.0005); and theophylline-glucose: 39% (n 41, p<0.005). A long-term arginine-glucose treatment was not superior to the shorter neonatal treatment. Histological examination revealed a higher degree of insulitis in diabetic than in non-diabetic animals but no difference according to the kind of treatment was observed. Finally, we found that the diabetes incidence in BB rats was higher in the first litter compared to subsequent litters (p=0.04). Thus, neonatal treatment with various beta-cell stimulatory agents reduces diabetes incidence in BB rats. The theory behind the study, that the treatment accelerates beta-cell maturation leading to increased immunological tolerance towards beta cells, is discussed.
INTRODUCTION
The idea of neonatal stimulation of beta cells in BB rats and NOD mice in order to reduce the diabetes incidence ) is inspired by two observations. Firstly, Type 1 diabetes is less frequent in children of Type 1 diabetic mothers than in children of diabetic fathers (Warram et al., 1984; Tilli and K6bberling, 1987; Rjasanowski et al., 1990) (Buschard et al., 1989) . Interestingly, a growing knowledge indicates that if the mothers develop Type 1 diabetes after the pregnancy, the children seem to have the same diabetes risk as children of diabetic fathers (Warram et al., 1984; Lorentzen et al., 1998) .
Secondly, antigen expression of the beta cells seems to be dependent on their functional state; at a high function there is a high expression. This *Corresponding author. Fax: +45-33 93 85 66, e-mail: buschard@dadlnet.dk has been found for the antigens corresponding to the (monoclonal) antibodies IC2 (Buschard et al., 1988; Aaen et al., 1990) , A2B5 Eisenbarth et al., 1982) , R2D6 (Appel et al., 1989) , and ICA (McCulloch et al., 1991) , and for GAD (Hao et al., 1994) and 64kDa antigen (K/impe et al., 1989) .
Normally, beta cells are immature at birth (Freinkel et al., 1984; Grasso et al., 1973; Otonkoski et al., 1988) whereas in the diabetic pregnancy the beta cells mature earlier (Heding et al., 1980) . Since diabetes is an autoimmune disease resulting from a break of self tolerance, we wanted to investigate whether neonatal betacell stimulation, and thereby early maturation of the beta cells like in the diabetic pregnancy with fetal hyperglycemia, could lower the diabetes incidence. Normally, neonatal beta cells are insensitive to glucose during the first two weeks of life ) but sensitive to arginine, glucagon, and theophylline (Otonkoski, 1988 In a long-term arginine-glucose treatment group (n=31), L-arginine (75mg/ml)-glucose (25 mg/ml) was given i.p. twice a day from the day of birth and during the 5 following days, afterwards once a week to the end of the study at a dose of 100 tl/6 g BW up to a maximum dose of 1000 tl. Control BB rats (n =36) were correspondingly given saline.
Histological Studies
The paraffin-embedded pancreases were cut into 4 tm sections and stained with hematoxylin and eosin. (Hald, 1957 The result of the examination of the islets for insulitis is shown in Table II. All the groups of diabetic rats had significantly higher scores than the non-diabetic rats. There were no differences between the various experimental groups. However, it should be noticed that overall the degree of insulitis was modest and massive insulitis was only rarely seen. Control rats with early diabetes development (before day 100) showed similar degrees of insulitis as rats that became diabetic after day 100 (1.44-0.1 vs. 1.14-0.1, (p > 0.10). Likewise, no differences were seen for treated diabetic animals (1.2 4-0.2 vs. 1.1 4-0.1 insulitis score).
The results of the different neonatal treatments can be seen in Figure 1 and Table I . The experimental BB rats received either arginine, glucagon, tolbutamide or theophylline, and the diabetes incidences were found to remain between 30% and 47%. There were no differ-
Studies of Litters and Sex
Litters contained more female than male BB rats in both the experimental and control groups (42.3% and 43.6% males, respectively). Litter sizes were similar in the experimental and the (Hansen et al., 1993) . In NOD mice the diabetes incidence has been found by our group to be reduced by neonatal treatment with glucose (Bock et al., 1991) . We have as yet no explanation for the discrepancy between NOD mice and BB rats in which glucose treatment per se does not significantly alter the diabetes incidence . Interestingly, female NOD mice treated with neonatal injections the first 6 days of life with I mg arginine and 0.5 mg glucose combined displayed diabetes earlier and with a higher incidence (Senecat et al., 1994) . Obviously, the outcome of arginine on the one hand and of pure glucose on the other is different, and the effect of these compounds on beta-cell maturation should be studied with molecular biological methods. In another approach of early beta-cell stimulation, 4-week old NOD female mice were fed with 1 to 1.75g glucose orally per day until the age of 30 weeks; at that time 37% of the experimental mice had developed diabetes compared to 86% of the controls (Vardi and Buschard, 1995) . Regarding tolbutamide, treatment starting at the time of weaning has resulted in a reduced diabetes incidence in NOD mice (Williams et al., 1993) (Ko et al., 1994 (Ihm et al., 1991) . Another study measured in vitro cytotoxicity mediated by mononuclear spleen cells from newly diabetic BB rats and found a significantly lower cytotoxicity towards islet cells from BB rats < 4 days old than towards islet cells from adult insulitis-free BB rat islets (Ekblond et al., 1995) . Islet cell maturation in BB rats-as evidenced by sensitivity to cytotoxicity-was not seen before the age of 21 days after birth (Ekblond et al., 1995) .
The finding in the present study-that the litter sequence number seems to influence the diabetes incidence in BB rats-is to our knowledge a new observation which may reflect that, among diabetes-prone rats, the risk of developing diabetes in the offspring decreases with maternal age; this parallels findings in humans (Warram et al., 1991) .
It has been suggested that the protection of the diabetic pregnancy against development of diabetes in the offspring may be due to a direct immunological mechanism (Dosch et al., 1993) . This might be mediated by placental transfer of autoantibodies which in the fetus, according to the immunological network theory, might raise specific regulator cells. However, offspring of Type 2 diabetic mothers also have lower incidence of Type 1 diabetes compared to children of Type 2 diabetic fathers (Green et al., 1994) and Type 2 diabetic mothers do not display autoantibodies. This may support the mechanism involving early stimulation of the beta-cells as suggested in this study.
